Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.

Source:http://linkedlifedata.com/resource/pubmed/id/12009282

Vaccine 2002 May 22 20 17-18 2263-77

Download in:

View as

Triples

General Info

PMID
12009282